Mesenteric vein thrombosis and vascular plasminogen activator

Arch Pathol Lab Med. 1983 Oct;107(10):541-2.

Abstract

A 60-year-old woman with livedo reticularis was examined for defective release of vascular plasminogen activator by a newly described chromogenic assay. Her activator level was only 0.007 Committee on Thrombolytic Agents (CTA) units/mL, compared with a mean of 0.19 CTA units/mL for 84 female controls. Subsequently, the patient died as a result of thrombosis of the portal, splenic, hepatic and superior mesenteric veins with small-bowel infarction. The patient's family had a history of deep and superficial vein thrombosis. Her family's medical history was similar to a recently described pedigree, with low levels of releasable plasminogen activator associated with venous thrombosis. We believe that mesenteric vein thrombosis is a serious potential consequence of defective release of vascular plasminogen activator.

Publication types

  • Case Reports
  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Female
  • Humans
  • Mesenteric Veins* / metabolism
  • Middle Aged
  • Pedigree
  • Plasminogen Activators / analysis
  • Plasminogen Activators / metabolism*
  • Thrombosis / genetics
  • Thrombosis / metabolism*
  • Thrombosis / mortality

Substances

  • Plasminogen Activators